Get started
Author

Regina Heidenreich

Angiogenesis drives psoriasis pathogenesis
2009 · Regina Heidenreich, Martin Röcken, et al. · International Journal of Experimental Pathology · 388
Cooperative Interaction of Hypoxia-inducible Factor-2α (HIF-2α) and Ets-1 in the Transcriptional Activation of Vascular Endothelial Growth Factor Receptor-2 (Flk-1)
2003 · Gerd Elvert, Andreas Kappel, et al. · Journal of Biological Chemistry · 275
Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines
2017 · Johannes Lutz, Sandra Lazzaro, et al. · npj Vaccines · 263
PDF
Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2
2002 · Peter Vajkoczy, Mohammad Farhadi, et al. · Journal of Clinical Investigation · 247
A novel, disruptive vaccination technology
2013 · Karl-Josef Kallen, Regina Heidenreich, et al. · Human Vaccines & Immunotherapeutics · 224
Local Gene Transfer of phVEGF-2 Plasmid by Gene-Eluting Stents
2004 · Dirk H. Walter, Manfred Cejna, et al. · Circulation · 213
De novo expression of vascular endothelial growth factor in human pancreatic cancer: Evidence for an autocrine mitogenic loop
2000 · Zofia Von Marschall, Thorsten Cramer, et al. · Gastroenterology · 190
PDF
mRNA mediates passive vaccination against infectious agents, toxins, and tumors
2017 · Moritz Thran, Jean Mukherjee, et al. · EMBO Molecular Medicine · 171
PDF
Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer
2014 · Martin Sebastian, Alexandros Papachristofilou, et al. · BMC Cancer · 143
PDF
Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity
2016 · Aleksandra Kowalczyk, Fatma Doener, et al. · Vaccine · 105
Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect
2012 · Mariola Fotin‐Mleczek, Kai Zanzinger, et al. · The Journal of Gene Medicine · 103
PDF
Design, Synthesis, and Biological Evaluation of Novel 3-Aryl-4-(1H-indole-3yl)-1,5-dihydro-2H-pyrrole-2-ones as Vascular Endothelial Growth Factor Receptor (VEGF-R) Inhibitors
2008 · Christian Peifer, Roland Selig, et al. · Journal of Medicinal Chemistry · 95
mRNA: A Novel Avenue to Antibody Therapy?
2019 · Thomas Schlake, Moritz Thran, et al. · Molecular Therapy · 93
PDF
mRNA Cancer Vaccines
2016 · Katja Fiedler, Sandra Lazzaro, et al. · Recent results in cancer research/Recent Results in Cancer Research · 88
A novel RNA‐based adjuvant combines strong immunostimulatory capacities with a favorable safety profile
2014 · Regina Heidenreich, Edith Jasny, et al. · International Journal of Cancer · 80
EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion
2009 · Alexandra Ziegler, Regina Heidenreich, et al. · Blood · 76
PDF
Signaling mechanism of extracellular RNA in endothelial cells
2009 · Silvia Fischer, Miwako Nishio, et al. · The FASEB Journal · 65
RNActive® Technology: Generation and Testing of Stable and Immunogenic mRNA Vaccines
2016 · Susanne Rauch, Johannes Lutz, et al. · Methods in molecular biology · 56
A New RNA-Based Adjuvant Enhances Virus-Specific Vaccine Responses by Locally Triggering TLR- and RLH-Dependent Effects
2017 · Annett Ziegler, Claudia Soldner, et al. · The Journal of Immunology · 50
Angiogenesis: The New Potential Target for the Therapy of Psoriasis?
2008 · Regina Heidenreich, Martin Röcken, et al. · Drug News & Perspectives · 50
RNA-based adjuvant CV8102 enhances the immunogenicity of a licensed rabies vaccine in a first-in-human trial
2019 · Fatma Doener, Henoch S. Hong, et al. · Vaccine · 49
PDF
mRNA-based vaccines synergize with radiation therapy to eradicate established tumors
2014 · Mariola Fotin-Mleczek, Kai Zanzinger, et al. · Radiation Oncology · 46
PDF
Simultaneous blockade of VEGFR‐1 and VEGFR‐2 activation is necessary to efficiently inhibit experimental melanoma growth and metastasis formation
2007 · Jens Gille, Regina Heidenreich, et al. · International Journal of Cancer · 43
PDF
Inhibition of solid tumor growth by gene transfer of VEGF receptor‐1 mutants
2004 · Regina Heidenreich, Marcia Machein, et al. · International Journal of Cancer · 42
Tumor endothelium-specific transgene expression directed by vascular endothelial growth factor receptor-2 (Flk-1) promoter/enhancer sequences.
2000 · R Heidenreich, A Kappel, et al. · PubMed · 36
Works count: 80
Citation count: 3,322
H-index: 25
I10-index: 31
Year
Topic
Type